Loss of opportunities in the diagnosis and treatment of primary obstetric antiphospholipid syndrome (POAPS): from theory to reality-Reference-Cited by-同舟云学术

Loss of opportunities in the diagnosis and treatment of primary obstetric antiphospholipid syndrome (POAPS): from theory to reality

Published:2024-03-04 Issue:5 Volume:43 Page:1615-1622
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Udry Sebastián,Latino José O.,Perez Stephanie Morales,Belizna Cristina,Aranda Federico,Esteve-Valverde Enrique,Wingeyer Silvia Perés,Romero Diego S. Fernández,Alijotas-Reig Jaume^ORCID,de Larrañaga Gabriela

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10067-023-06846-8.pdf

Reference19 articles.

1. Meroni PL, Borghi MO, Grossi C, Chighizola CB, Durigutto P, Tedesco F (2018) Obstetric and vascular antiphospholipid syndrome: same antibodies but different diseases? Nat Rev Rheumatol 14(7):433–440. https://doi.org/10.1038/s41584-018-0032-6

2. Radin M, Foddai SG, Barinotti A, Cecchi I, Rubini E, Sciascia S et al (2021) Reducing the diagnostic delay in antiphospholipid syndrome over time: a real world observation. Orphanet J Rare Dis 16(1):280. https://doi.org/10.1186/s13023-021-01906-1

3. Faviez C, Chen X, Garcelon N, Neuraz A, Knebelmann B, Salomon R et al (2020) Diagnosis support systems for rare diseases: a scoping review. Orphanet J Rare Dis 15(1):94. https://doi.org/10.1186/s13023-020-01374-z

4. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thrombosis Haemostasis : JTH 4(2):295–306. https://doi.org/10.1111/j.1538-7836.2006.01753.x

5. Bulletins--Obstetrics ACoP. (2002) ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstetrics and gynecology. 99(1):159–67. https://doi.org/10.1016/s0029-7844(01)01747-1.